Baxter International (US Generic Injectables Business) Overview

  • Status

  • Acquired/​Merged

  • Employees

  • 650

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Baxter International (US Generic Injectables Business) General Information

Description

Provider of generic injectables. The business unit offers generic injectable in vials and ampoules, chronic pain, anti-infective and anti-emetic products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Acquirer
Hikma Pharmaceuticals
Primary Office
  • IL
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baxter International (US Generic Injectables Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baxter International (US Generic Injectables Business)‘s full profile, request access.

Request a free trial

Baxter International (US Generic Injectables Business) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Baxter International (US Generic Injectables Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baxter International (US Generic Injectables Business)‘s full profile, request access.

Request a free trial